Cancer of the Prostate: Molecular Genetics
215
Lee, W.H.,
Isaacs, W.B.,
Bova, G.S.,
Nel-
son, W.G.
(1997)
CG
island
methylation
changes near the GSTP1 gene in prostatic
carcinoma
cells
detected
using
the
poly-
merase chain reaction: a new prostate cancer
biomarker,
Cancer Epidemiol. Biomarkers Prev.
6
, 443–450.
Lee, W.H.,
Morton, R.A.,
Epstein, J.I.,
et al.
(1994) Cytidine methylation of regulatory
sequences
near
the
pi-class
glutathione
Stransferase
gene
accompanies
human
prostatic carcinogenesis,
Proc. Natl. Acad. Sci.
U.S.A.
91
, 11733–11737.
Leung, H.Y., Dickson, C., Robson, C.N., Neal,
D.E.
(1996)
Over-expression
of
Fbroblast
growth factor-8 in human prostate cancer,
Oncogene
12
, 1833–1835.
Leung, H.Y., Mehta, P., Gray, L.B., et al. (1997)
Keratinocyte
growth
factor
expression
in
hormone insensitive prostate cancer,
Oncogene
15
, 1115–1120.
Li, J., Yen, C., Liaw, D., et al. (1997) PTEN, a
putative protein tyrosine phosphatase gene
mutated in human brain, breast, and prostate
cancer,
Science
275
, 1943–1947.
Limon, J.,
Lundgren, R.,
Elfving, P.,
et al.
(1989)
Double
minutes
in
two
primary
adenocarcinomas of prostate,
Cancer Genet.
Cytogenet.
39
, 191–194.
Lin, Y., Uemura, H., ±ujinami, K., et al. (1997)
Telomerase activity in primary prostate cancer,
J. Urol.
157
, 1161–1165.
Loeb, L.A.
(1994)
Microsatellite
instability:
marker of a mutator phenotype in cancer,
Cancer Res.
54
, 5059–5063.
Lokeshwar, B.L.,
Lokeshwar, V.B.,
Block, N.L.
(1995)
Expression
of
CD44
in
prostate
cancer cells: association with cell proliferation
and invasive potential,
Anticancer Res.
15
,
1191–1198.
Lou, W.,
Krill, D.,
Dhir, R.,
et al.
(1999)
Methylation
of
the
CD44
metastasis
suppressor gene in human prostate cancer,
Cancer Res.
59
, 2329–2331.
Lowe, S.W., Schmitt, E.M., Smith, S.W., et al.
(1993) p53 is required for radiation-induced
apoptosis in mouse thymocytes,
Nature
362
,
847–849.
Lundgren, R.,
Manhad, N.,
Heim, S.,
et al.
(1992) Cytogenetic analysis of 57 primary pro-
static adenocarcinomas,
Genes Chromosomes
Cancer
4
, 16–24.
M
a
c
G
r
o
g
a
n
,
D
.
,L
e
v
y
,
A
.
,B
o
v
a
,
G
.
S
.
,e
t
a
l
.
(1996) Structure and methylation-associated
silencing of a gene within a homozygously
deleted region of human chromosome band
8p22,
Genomics
35
, 55–65.
Macoska, J.A., Trybus, T.M., Benson, P.D., et al.
(1995) Evidence for three tumor suppressor
gene loci on chromosome 8p in human
prostate cancer,
Cancer Res.
55
, 5390–5395.
Macoska, J.A., Trybus, T.M., Sakr, W.A., et al.
(1994)
±luorescence
in
situ
hybridization
analysis of 8p allelic loss and chromosome
8 instability in human prostate cancer,
Cancer
Res.
54
, 3824–3830.
Makridakis, N.M., Ross, R.K., Pike, M.C., et al.
(1999) Association of mis-sense substitution in
SRD5A2
gene with prostate cancer in African-
American and Hispanic men in Los Angeles,
USA,
Lancet
354
, 975–978.
Mansson, P.E.,
Adams, P.,
Kan, M.,
McKee-
han, W.L. (1989) Heparinbinding growth fac-
tor gene expression and receptor character-
istics in normal rat prostate and two trans-
plantable rate prostate tumors,
Cancer Res.
49
,
2485–2494.
Matusik, R.J., ±leming, W.H., Hamel, A., et al.
(1987) Expression of the c-myc proto-oncogene
in prostatic tissue,
Prog. Clin. Biol. Res.
239
,
91–112.
McIndoe, R.A., Stanford, J.L., Gibbs, M., et al.
(1997) Linkage analysis of 49 high-risk families
does not support a common familial prostate
cancer-susceptibility gene at 1q24-25,
Am. J.
Hum. Genet.
61
, 347–353.
McMenamin, M.E., Soung, P., Perera, S., et al.
(1999) Loss of PTEN expression in parafFn-
embedded primary prostate cancer correlates
with high Gleason score and advanced stage,
Cancer Res.
59
, 4291–4296.
McPherson, J.D.,
Morton, R.A.,
Ewing, C.M.,
et al. (1994) Assignment of the human
α
-
catenin gene (CTNNA1) to chromosome 5q21-
q22,
Genomics
19
, 188–190.
Mellinghoff, I.K., Tran, C., Sawyers, C.L. (2002)
Growth
inhibitory
effects
of
the
dual
ErbB1/ErbB2 tyrosine kinase inhibitor PKI-
166 on human prostate cancer xenografts,
Cancer Res.
62
(18), 5254–5259.
Mellon, K., Thompson, S., Charlton, R.G., et al.
(1992) p53, c-erbB-2, and the epidermal growth
factor receptor in the benign and malignant
prostate,
J. Urol.
147
, 496–499.
Micale, M.A.,
Mohamed, A.,
Sakr, W.,
et al.
(1992)
Cytogenetics
of
primary
prostatic
adenocarcinoma. Clonality and chromosome
previous page 889 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 891 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off